You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 21 Nov 641.20 5.25
(0.83%)
OPEN

639.00

HIGH

647.20

LOW

636.50

NSE 00:00 | 21 Nov 641.15 5.75
(0.90%)
OPEN

635.40

HIGH

647.25

LOW

635.40

OPEN 639.00
PREVIOUS CLOSE 635.95
VOLUME 29973
52-Week high 711.55
52-Week low 483.60
P/E 14.02
Mkt Cap.(Rs cr) 18,095
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 639.00
CLOSE 635.95
VOLUME 29973
52-Week high 711.55
52-Week low 483.60
P/E 14.02
Mkt Cap.(Rs cr) 18,095
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is a research-driven global integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   18,095
EPS - TTM () [*S] 45.75
P/E Ratio (X) [*S] 14.02
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 19 Sep 2018
Dividend Yield (%) 0.31
Book Value / Share () [*S] 408.80
P/B Ratio () [*S] 1.57
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2018 Sep 2017 % Chg
Net Sales 2581.34 2256.59 14.39
Other Income 307.06 29.73 932.83
Total Income 2888.39 2286.32 26.33
Total Expenses 2141.23 1868.19 14.62
Operating Profit 747.17 418.12 78.7
Net Profit 414 214.12 93.35
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Torrent Pharma. 1636.80 -0.41 27697.93
Alkem Lab 1932.90 -0.75 23107.82
Glaxosmi. Pharma 1350.40 -0.42 22877.13
Glenmark Pharma. 641.20 0.83 18094.66
Abbott India 7554.40 -0.83 16053.10
Sanofi India 6071.60 -0.51 13982.90
Natco Pharma 733.30 0.10 13547.72
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.54
Banks/FIs 2.82
FIIs 30.90
Insurance 0.00
Mutual Funds 4.28
Indian Public 9.81
Custodians 0.00
Other 5.47
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
03/05 HDFC Securities Buy 894 PDF IconDetails
20/12 IDBI Capital Accumulate 941 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.11% -2.13% 0.16% 0.22%
1 Month 6.96% 7.04% 2.58% 2.88%
3 Month 1.09% 0.83% -8.06% -8.39%
6 Month 28.02% 28.01% 1.69% 0.79%
1 Year 8.24% 8.45% 5.14% 2.65%
3 Year -33.58% -33.73% 36.07% 34.92%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 636.50
647.20
Week Low/High 628.00
688.00
Month Low/High 585.00
688.00
YEAR Low/High 483.60
712.00
All TIME Low/High 1.89
1262.00